GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Great Basin Scientific Inc (GREY:GBSNQ) » Definitions » Beta

Great Basin Scientific (Great Basin Scientific) Beta : N/A (As of May. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Great Basin Scientific Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-04), Great Basin Scientific's Beta is Not available.


Great Basin Scientific Beta Historical Data

The historical data trend for Great Basin Scientific's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Basin Scientific Beta Chart

Great Basin Scientific Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16
Beta
- - - - -

Great Basin Scientific Quarterly Data
Dec12 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Great Basin Scientific's Beta

For the Diagnostics & Research subindustry, Great Basin Scientific's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Great Basin Scientific's Beta Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Great Basin Scientific's Beta distribution charts can be found below:

* The bar in red indicates where Great Basin Scientific's Beta falls into.



Great Basin Scientific Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Great Basin Scientific  (GREY:GBSNQ) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Great Basin Scientific Beta Related Terms

Thank you for viewing the detailed overview of Great Basin Scientific's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Great Basin Scientific (Great Basin Scientific) Business Description

Traded in Other Exchanges
N/A
Address
420 East South Temple, Suite 520, Salt Lake City, UT, USA, 84111
Great Basin Scientific Inc is the United States based molecular diagnostic testing company. It is focused on the development and commercialization of molecular diagnostic platform designed to test for the infectious disease, especially hospital-acquired infections. Molecular diagnostic testing reduces test time from days to hours compared to culture methods. The company's system includes an analyzer, which it provides for the customers' use without charge in the United States, and a diagnostic cartridge, which it sells to the customers. The group derives its revenue from the sale of single-use assays sold in the United States, the European Union, and New Zealand, of which majority of the revenue is generated from the United States.

Great Basin Scientific (Great Basin Scientific) Headlines

No Headlines